Dipalmitoleoyl-phosphatidylethanolamine induces apoptosis of NCI-H28 malignant mesothelioma cells

Anticancer Research

Volumn 34, Issue 4, 2014, Pages 1759-1764

  Kaku, Yoshiko ^a   Tsuchiya, Ayako ^a   Kanno, Takeshi ^a   Nakano, Takashi ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Apoptosis; Dipalmitoleoyl sn glycero 3 phosphoethanolamine; Malignant pleural mesothelioma; Protein phosphatase

Indexed keywords

1,2 DIPALMITOLEOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ETHANOLAMINE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN TYROSINE PHOSPHATASE 1B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CARBOXYLESTERASE; DIPALMITOLEOYLPHOSPHATIDYLETHANOLAMINE; PROTEIN PHOSPHATASE METHYLESTERASE 1; PROTEIN PHOSPHATASE METHYLESTERASE-1; PTPN1 PROTEIN, HUMAN; UNSATURATED FATTY ACID;

APOPTOSIS; ARTICLE; ATTENUATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALIGNANT MESOTHELIOMA; MESOTHELIOMA CELL LINE; MESOTHELIUM CELL; MTT ASSAY; NICK END LABELING; PLEURA MESOTHELIOMA; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CELL SURVIVAL; DIPALMITOLEOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE; DRUG EFFECT; ENZYME ACTIVATION; LUNG TUMOR; MESOTHELIOMA; METABOLISM; PLEURA TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; DIPALMITOLEOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE; MALIGNANT PLEURAL MESOTHELIOMA; PROTEIN PHOSPHATASE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBOXYLIC ESTER HYDROLASES; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; ETHANOLAMINES; FATTY ACIDS, UNSATURATED; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MESOTHELIOMA; PLEURAL NEOPLASMS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1;

EID: 84902338468     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Raja S, Murthy SC and Mason DP: Malignant pleural mesothelioma. Curr Oncol Rep 13: 259-264, 2011.
2. Kanno T, Tsuchiya A, Shimizu T, Tanaka A and Nishizaki T: Indomethacin serves as a potential inhibitor of protein phosphatases. Cell Physiol Biochem 30: 1014-1022, 2012.
3. Yaguchi T, Muramoto M, Nakano T and Nishizaki T: Urinary trypsin inhibitor suppresses migration of malignant mesothelioma. Cancer Lett 288: 214-218, 2010.
4. Nogi Y, Kanno T, Nakano T, Fujita Y, Tabata C, Fukuoka K, Gotoh A and Nishizaki T: AMP converted from intracellularly transported adenosine up-regulates p53 expression to induce malignant pleural mesothelioma cell apoptosis. Cell Physiol Biochem 30: 61-74, 2012.
5. Deeba F, Tahseen HN, Sharad KS, Ahmad N, Akhtar S, Saleemuddin M and Mohammad O: Phospholipid diversity: Correlation with membrane-membrane fusion events. Biochim Biophys Acta 1669: 170-181, 2005.
6. Emoto K, Kobayashi T, Yamaji A, Aizawa H, Yahara I, Inoue K and Umeda M: Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc Natl Acad Sci USA 93: 12867-12872, 1996.
7. Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, Mizushima N, Tanida I, Kominami E, Ohsumi M, Noda T and Ohsumi Y: A ubiquitin-like system mediates protein lipidation. Nature 408: 488-492, 2000.
8. Emoto K, Toyama-Sorimachi N, Karasuyama H, Inoue K and Umeda M: Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp Cell Res 232: 430-434, 1997.
9. Yaguchi T, Nagata T and Nishizaki T: 1,2-dilinoleoyl-sn-glycero-3-phosphoethanolamine ameliorates age-related spatial memory deterioration by preventing neuronal cell death. Behav Brain Funct 6: 52. doi:10.1186/1744-9081-6-52, 2010.
10. Pavlovic Z and Bakovic M: Regulation of phosphatidylethanolamine homeostasis - The critical role of CTP: phosphoethanolamine cytidylyltransferase (Pcyt2). Int J Mol Sci 14: 2529-2550, 2013.